Cargando…

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas

Anaplastic (ATC) and certain follicular thyroid-carcinomas (FTCs) are radioresistant. The Phosphatidylinositide 3-kinase (PI3K) pathway is commonly hyperactivated in thyroid-carcinomas. PI3K can modify the PI3K-related kinases (PIKKs) in response to radiation: How PIKKs interact with PI3K and contri...

Descripción completa

Detalles Bibliográficos
Autores principales: Burrows, Natalie, Williams, Joseph, Telfer, Brian A, Resch, Julia, Valentine, Helen R, Fitzmaurice, Richard J, Eustace, Amanda, Irlam, Joely, Rowling, Emily J, Hoang-Vu, Cuong, West, Catharine M, Brabant, Georg, Williams, Kaye J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325350/
https://www.ncbi.nlm.nih.gov/pubmed/27527858
http://dx.doi.org/10.18632/oncotarget.11056
_version_ 1782510364411297792
author Burrows, Natalie
Williams, Joseph
Telfer, Brian A
Resch, Julia
Valentine, Helen R
Fitzmaurice, Richard J
Eustace, Amanda
Irlam, Joely
Rowling, Emily J
Hoang-Vu, Cuong
West, Catharine M
Brabant, Georg
Williams, Kaye J
author_facet Burrows, Natalie
Williams, Joseph
Telfer, Brian A
Resch, Julia
Valentine, Helen R
Fitzmaurice, Richard J
Eustace, Amanda
Irlam, Joely
Rowling, Emily J
Hoang-Vu, Cuong
West, Catharine M
Brabant, Georg
Williams, Kaye J
author_sort Burrows, Natalie
collection PubMed
description Anaplastic (ATC) and certain follicular thyroid-carcinomas (FTCs) are radioresistant. The Phosphatidylinositide 3-kinase (PI3K) pathway is commonly hyperactivated in thyroid-carcinomas. PI3K can modify the PI3K-related kinases (PIKKs) in response to radiation: How PIKKs interact with PI3K and contribute to radioresistance in thyroid-carcinomas is unknown. Further uncertainties exist in how these interactions function under the radioresistant hypoxic microenvironment. Under normoxia/anoxia, ATC (8505c) and FTC (FTC-133) cells were irradiated, with PI3K-inhibition (via GDC-0941 and PTEN-reconstitution into PTEN-null FTC-133s) and effects on PIKK-activation, DNA-damage, clonogenic-survival and cell cycle, assessed. FTC-xenografts were treated with 5 × 2 Gy, ± 50 mg/kg GDC-0941 (twice-daily; orally) for 14 days and PIKK-activation and tumour-growth assessed. PIKK-expression was additionally assessed in 12 human papillary thyroid-carcinomas, 13 FTCs and 12 ATCs. GDC-0941 inhibited radiation-induced activation of Ataxia-telangiectasia mutated (ATM), ATM-and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Inhibition of ATM and DNA-PKcs was PI3K-dependent, since activation was reduced in PTEN-reconstituted FTC-133s. Inhibition of PIKK-activation was greater under anoxia: Consequently, whilst DNA-damage was increased and prolonged under both normoxia and anoxia, PI3K-inhibition only reduced clonogenic-survival under anoxia. GDC-0941 abrogated radiation-induced cell cycle arrest, an effect most likely linked to the marked inhibition of ATR-activation. Importantly, GDC-0941 inhibited radiation-induced PIKK-activation in FTC-xenografts leading to a significant increase in time taken for tumours to triple in size: 26.5 ± 5 days (radiation-alone) versus 31.5 ± 5 days (dual-treatment). PIKKs were highly expressed across human thyroid-carcinoma classifications, with ATM scoring consistently lower. Interestingly, some loss of ATM and DNA-PKcs was observed. These data provide new insight into the mechanisms of hypoxia-associated radioresistance in thyroid-carcinoma.
format Online
Article
Text
id pubmed-5325350
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53253502017-03-23 Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas Burrows, Natalie Williams, Joseph Telfer, Brian A Resch, Julia Valentine, Helen R Fitzmaurice, Richard J Eustace, Amanda Irlam, Joely Rowling, Emily J Hoang-Vu, Cuong West, Catharine M Brabant, Georg Williams, Kaye J Oncotarget Research Paper Anaplastic (ATC) and certain follicular thyroid-carcinomas (FTCs) are radioresistant. The Phosphatidylinositide 3-kinase (PI3K) pathway is commonly hyperactivated in thyroid-carcinomas. PI3K can modify the PI3K-related kinases (PIKKs) in response to radiation: How PIKKs interact with PI3K and contribute to radioresistance in thyroid-carcinomas is unknown. Further uncertainties exist in how these interactions function under the radioresistant hypoxic microenvironment. Under normoxia/anoxia, ATC (8505c) and FTC (FTC-133) cells were irradiated, with PI3K-inhibition (via GDC-0941 and PTEN-reconstitution into PTEN-null FTC-133s) and effects on PIKK-activation, DNA-damage, clonogenic-survival and cell cycle, assessed. FTC-xenografts were treated with 5 × 2 Gy, ± 50 mg/kg GDC-0941 (twice-daily; orally) for 14 days and PIKK-activation and tumour-growth assessed. PIKK-expression was additionally assessed in 12 human papillary thyroid-carcinomas, 13 FTCs and 12 ATCs. GDC-0941 inhibited radiation-induced activation of Ataxia-telangiectasia mutated (ATM), ATM-and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Inhibition of ATM and DNA-PKcs was PI3K-dependent, since activation was reduced in PTEN-reconstituted FTC-133s. Inhibition of PIKK-activation was greater under anoxia: Consequently, whilst DNA-damage was increased and prolonged under both normoxia and anoxia, PI3K-inhibition only reduced clonogenic-survival under anoxia. GDC-0941 abrogated radiation-induced cell cycle arrest, an effect most likely linked to the marked inhibition of ATR-activation. Importantly, GDC-0941 inhibited radiation-induced PIKK-activation in FTC-xenografts leading to a significant increase in time taken for tumours to triple in size: 26.5 ± 5 days (radiation-alone) versus 31.5 ± 5 days (dual-treatment). PIKKs were highly expressed across human thyroid-carcinoma classifications, with ATM scoring consistently lower. Interestingly, some loss of ATM and DNA-PKcs was observed. These data provide new insight into the mechanisms of hypoxia-associated radioresistance in thyroid-carcinoma. Impact Journals LLC 2016-08-04 /pmc/articles/PMC5325350/ /pubmed/27527858 http://dx.doi.org/10.18632/oncotarget.11056 Text en Copyright: © 2016 Burrows et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Burrows, Natalie
Williams, Joseph
Telfer, Brian A
Resch, Julia
Valentine, Helen R
Fitzmaurice, Richard J
Eustace, Amanda
Irlam, Joely
Rowling, Emily J
Hoang-Vu, Cuong
West, Catharine M
Brabant, Georg
Williams, Kaye J
Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
title Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
title_full Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
title_fullStr Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
title_full_unstemmed Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
title_short Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
title_sort phosphatidylinositide 3-kinase (pi3k) and pi3k-related kinase (pikk) activity contributes to radioresistance in thyroid carcinomas
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325350/
https://www.ncbi.nlm.nih.gov/pubmed/27527858
http://dx.doi.org/10.18632/oncotarget.11056
work_keys_str_mv AT burrowsnatalie phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT williamsjoseph phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT telferbriana phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT reschjulia phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT valentinehelenr phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT fitzmauricerichardj phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT eustaceamanda phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT irlamjoely phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT rowlingemilyj phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT hoangvucuong phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT westcatharinem phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT brabantgeorg phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas
AT williamskayej phosphatidylinositide3kinasepi3kandpi3krelatedkinasepikkactivitycontributestoradioresistanceinthyroidcarcinomas